MedTrace Logo

Lens Wear Schedules and End-of-Day Comfort

NCT01433549 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2013-05-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to assess the impact of lens-free (recovery) intervals of varying lengths on end-of-day comfort and tear film changes with daily contact lens wear.

Conditions

  • Myopia

Interventions

DEVICE

Lotrafilcon B

Commercially marketed, silicone hydrogel, single-vision contact lens FDA-approved for daily wear and extended (overnight) wear up to 6 nights.

DEVICE

Senofilcon A

Commercially marketed, silicone hydrogel, single-vision contact lens FDA-approved for daily wear and extended (overnight) wear up to 6 nights.

Sponsors & Collaborators

  • University of Waterloo

    collaborator OTHER

  • CIBA VISION

    lead INDUSTRY

Principal Investigators

  • Lyndon Jones, PhD FCOptom FAAO, Director · Centre for Contact Lens Research, School of Optometry, University of Waterloo

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01433549 on ClinicalTrials.gov